JH "a proven, inspiring leader"

Quote
anonymous said:
It is past time for the leaders - and I say that lightly to get out of these ( not all RBD’s) accounts with the reps
and do admin or something. When you go in an office with a RBD for a regular call , it does not fare well. Most MD’s are not going to come back if they know a manager is there. It looks so primary care and the offices don’t like it. More times than not , my RBD couldn’t have a clinical conversation if their lives depended on it and they truly think that they are there to coach. What a joke.
Click to expand...
It starts at the top. Anyone there when Len said to the training class 'some of you will be fired in your first year" greatest motivational speaker in history. I was not there but the stories are so consistent. If this is the attitutde toward the field from the top nothing will change. Primary care sales might actually work with dupixent. total failure of an approach for oncology. if top leaders in oncology don't know the difference they can't speak up and change. Regeneron is definitely not an oncology company and will never be. Look for us to get spun off. You heard it here first
 






anonymous said:
Has anyone noticed the stock price has gone done like 15% in the last 30 days? Anyone have a good answer as to why? Does sales performance with Libtayo and Eylea HD have anything to do with it?
Click to expand...
Don't flatter yourself Libtayo - you are a blip on the radar without threats to anyone. Eylea might be causing it. We ain't converting share like Uncle Len wants us to!
 






But seriously why have Libtayo sales been slower then Dupixent, Eylea HD? What are they so small comparted to the rest of the class? Was it a losing strategy to make CSCC as important as Lung Cancer? Who is responsble for that?
 
























anonymous said:
Has anyone noticed the stock price has gone done like 15% in the last 30 days? Anyone have a good answer as to why? Does sales performance with Libtayo and Eylea HD have anything to do with it?
Click to expand...
You obviously don't follow important product news. Stock price is falling because of Eylea biosimilar competition. Stock doesn't drop due to Libtayo or oncology pipeline. All youse hating on JH should know he is irrelevant in so many ways. I only got sympathy for the guy. It's tragic how he looks today compared to earlier photos. He aged 20 years in 3 due to high stress handling the part of the company worth the least where he's done a shitty job. MM's job is to coach the guy to improve and have a healthier life. Or replace him with someone who doesn't look like an aging zombie soon-to-be corpse. Same with KC since he's done a shitty job too.
 












anonymous said:
Has anyone noticed the stock price has gone done like 15% in the last 30 days? Anyone have a good answer as to why? Does sales performance with Libtayo and Eylea HD have anything to do with it?
Click to expand...
Stock price got slammed more than 10% today and the company market cap is down 30% from the 52 week high. Our problems are bigger than products. Clearly we suck with 7 of Lib where barely hitting the 1B sales mark. We also suck with Eylea HD conversion and Amgen and other biosimilars ready to eat our lunch and market. We also aren't doing well on our overall financials and "narrowing margins". This kind of performance happens when the arrogance of many leaders out-grows the company's ability to execute on sound business goals and mobilize all employees including sales and marketing. Bad career choice, oh well
 






anonymous said:
Stock price got slammed more than 10% today and the company market cap is down 30% from the 52 week high. Our problems are bigger than products. Clearly we suck with 7 of Lib where barely hitting the 1B sales mark. We also suck with Eylea HD conversion and Amgen and other biosimilars ready to eat our lunch and market. We also aren't doing well on our overall financials and "narrowing margins". This kind of performance happens when the arrogance of many leaders out-grows the company's ability to execute on sound business goals and mobilize all employees including sales and marketing. Bad career choice, oh well
Click to expand...
The launch of HD was impacted by the ARROGANCE:
-lack of data less than every 8 weeks (so now the studies are being done),
- pricing higher than faricimab,
- being late to the rebate party
- feel free to add your thoughts…..
 






anonymous said:
The launch of HD was impacted by the ARROGANCE:
-lack of data less than every 8 weeks (so now the studies are being done),
- pricing higher than faricimab,
- being late to the rebate party
- feel free to add your thoughts…..
Click to expand...
Looks right. And also why the hell would we run DTC ads for E-HD in such a reactive way, after never having run these ads before with E? The biggest problem is we started all of this way too late so it looks 100% reactive and afraid of the new kids. I guess at the time management thought since we are the greatest science company ever known to the universe, no biosimilar would be able to take over anything. We said, "the hell with running new trials" to show that HD is as sound or better than non-HD aflibercept. The whole strategy started too late. Either any of the teams like commercial didn't think of it, present it, fight for it.... or senior management figured we don't need it. Really bad decisions made. And speaking of commercial and of bad decisions.. JH is the biggest loser of all - who the fuck hired that guy???? Everyone knows he's all talk and fluff, doens't know shit, and can't manage a commercial team or any commercial issue through the woods and out of a paper bag. The guys is a complete flunkee and now heading up oncology... what a fucking house of cards AND.... MM is also quite clueless as is everyone else on the commercial leadership team..... probably with DS as the exception. A complete overhaul of commercial needed!
 






Team, let's remember this: Phonies at all levels of management eventually get found out. Those of us who have been around here long enough or at other companies have seen this. Be patient, stick around. Keep Calm and Sell More Regeneron Product
 






















































Top Bottom
Back
Quote